As BMPR-II loss does not alter the BMP9- or BMP10-dependent inhibition of CCL2 production by HPAECs, increased CCL2 production caused by BMPR-II loss and resistance to BMP9 and BMP10 is unlikely to contribute directly to PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.